9 Results

People

  1. Cheung
    Cheung
  2. Kramer
    Kramer
  3. Kushner
    Kushner
  4. Modak
    Modak
  5. Bajorin
    Bajorin
  6. Chapman
    Chapman
  7. Diaz
    Diaz
  8. Dunkel
    Dunkel
  9. Flynn
    Flynn
  10. Gerald
    Gerald

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  2. Neuro-Oncology Service (4)
  3. Pediatrics, Department of (4)
  4. Department of Medicine (3)
  5. GSK Faculty (3)
  6. Neuroblastoma Service (3)
  7. Solid Tumor Oncology Division (3)
  8. Tow Center for Developmental Oncology (TCDO) (3)
  9. Center for Pancreatic Cancer Research (2)
  10. Genitourinary Oncology Service (2)
  1. "cancer immunotherapy"
  2. "European Journal of Cancer"
Formats
  1. Journal Article (8)
  2. Conference Paper (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  2. Neuro-Oncology Service (4)
  3. Pediatrics, Department of (4)
  4. Department of Medicine (3)
  5. GSK Faculty (3)
  6. Neuroblastoma Service (3)

More Groups

People
  1. Kim Kramer (3)
  2. Nai-Kong Cheung (3)
  3. Brian Kushner (2)
  4. Shakeel Modak (2)
  5. Dean Bajorin (1)
  6. Gopakumar Iyer (1)

More People

Years
  1. 2024 (2)
  2. 2022 (1)
  3. 2020 (1)
  4. 2017 (1)
  5. 2011 (1)
  6. 2009 (2)

More Years

Publications
  1. European Journal of Cancer (9)
Publishers
  1. Elsevier Inc. (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
    Journal Article

    Brahmer, J. R.; Long, G. V.; Hamid, O.; Garon, E. B.; Herbst, R. S.; Andre, T.; Armand, P.; Bajorin, D.; Bellmunt, J.; Burtness, B.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations
    Journal Article

    Janku, F.; Kim, T. M.; Iyer, G.; Spreafico, A.; Elez, E.; de Jonge, M.; Yamamoto, N.; van der Wekken, A. J.; Ascierto, P. A.; Maur, M.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy
    Journal Article

    Dercle, L.; Ammari, S.; Roblin, E.; Bigorgne, A.; Champiat, S.; Taihi, L.; Plaian, A.; Hans, S.; Lakiss, S.; Tselikas, L.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
    Journal Article

    Hauschild, A.; Ascierto, P. A.; Schadendorf, D.; Grob, J. J.; Ribas, A.; Kiecker, F.; Dutriaux, C.; Demidov, L. V.; Lebbé, C.; Rutkowski, P.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
    Journal Article

    Geoerger, B.; Bergeron, C.; Gore, L.; Sender, L.; Dunkel, I. J.; Herzog, C.; Brochez, L.; Cruz, O.; Nysom, K.; Berghorn, E.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma
    Journal Article

    Kushner, B. H.; Kramer, K.; Modak, S.; Yataghene, K.; Cheung, N. K. V.
    European Journal of Cancer (2011)

    Fulltext@MSK | Save
  • Management and outcome of stage 3 neuroblastoma
    Journal Article

    Modak, S.; Kushner, B. H.; LaQuaglia, M. P.; Kramer, K.; Cheung, N. K. V.
    European Journal of Cancer (2009)

    Fulltext@MSK | Save
  • Improving the efficacy of cancer immunotherapy
    Journal Article

    Copier, J.; Dalgleish, A. G.; Britten, C. M.; Finke, L. H.; Gaudernack, G.; Gnjatic, S.; Kallen, K.; Kiessling, R.; Schuessler-Lenz, M.; Singh, H.; more...
    European Journal of Cancer (2009)

    Fulltext@MSK | Save
  • Monoclonal antibody to human Trk-A: Diagnostic and therapeutic potential in neuroblastoma
    Conference Paper

    Kramer, K.; Gerald, W.; Lesauteur, L.; Saragovi, H. U.; Cheung, N. K. V.
    Elsevier Inc. (1997)

    Fulltext@MSK | Save